The best Clinical Endocrinology source in the world, and FREE.

Endotext requires free registration
Login or Register

Menu

Skip to content
  • Home / Sections
  • Clinical Guidelines
  • Webinar Case Studies
  • Editorial Team
  • Country Associates
  • About
  • Instructions for Authors

fig4

Published July 21, 2016 at 652 × 546 in Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes.
← Previous Next →

Figure 4. Comparison of repaglinide and nateglinide. Data from (61)

  • Agreement on Use
  • Supporters
  • Donations
  • Privacy Policy
  • Instructions for Authors (5/03/23)

Copyright © 2000-2024, MDText.com, Inc. All rights reserved.